ArticleNPJ precision oncology2026
Treatment adherence and clinical outcomes of osimertinib in minority patients with advanced EGFR mutated NSCLC.
Matthew Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it